Lok AS - Search Results

1

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group. Morishima C, et al. Among authors: lok as. Hepatology. 2006 Aug;44(2):360-7. doi: 10.1002/hep.21265. Hepatology. 2006. PMID: 16871570 Clinical Trial.

2

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.

Chu CJ, Hussain M, Lok AS. Chu CJ, et al. Among authors: lok as. Hepatology. 2002 Dec;36(6):1408-15. doi: 10.1053/jhep.2002.36949. Hepatology. 2002. PMID: 12447866 Free article.

3

HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C.

Wai CT, Chu CJ, Hussain M, Lok AS. Wai CT, et al. Among authors: lok as. Hepatology. 2002 Dec;36(6):1425-30. doi: 10.1053/jhep.2002.37139. Hepatology. 2002. PMID: 12447868 Free article. Clinical Trial.

4

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. Wai CT, et al. Among authors: lok as. Hepatology. 2003 Aug;38(2):518-26. doi: 10.1053/jhep.2003.50346. Hepatology. 2003. PMID: 12883497 Free article.

5

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M. Lok AS, et al. Gastroenterology. 2003 Dec;125(6):1714-22. doi: 10.1053/j.gastro.2003.09.033. Gastroenterology. 2003. PMID: 14724824 Clinical Trial.

6

Chronic hepatitis B: update of recommendations.

Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Lok AS, et al. Hepatology. 2004 Mar;39(3):857-61. doi: 10.1002/hep.20110. Hepatology. 2004. PMID: 14999707 Free article. No abstract available.

7

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Lok AS, et al. Hepatology. 2005 Aug;42(2):282-92. doi: 10.1002/hep.20772. Hepatology. 2005. PMID: 15986415 Free article.

8

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group. Di Bisceglie AM, et al. Among authors: lok as. J Hepatol. 2005 Sep;43(3):434-41. doi: 10.1016/j.jhep.2005.03.019. J Hepatol. 2005. PMID: 16136646 Clinical Trial.

9

Evolution of multi-drug resistant hepatitis B virus during sequential therapy.

Yim HJ, Hussain M, Liu Y, Wong SN, Fung SK, Lok AS. Yim HJ, et al. Among authors: lok as. Hepatology. 2006 Sep;44(3):703-12. doi: 10.1002/hep.21290. Hepatology. 2006. PMID: 16941700

10

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group. Everson GT, et al. Among authors: lok as. Hepatology. 2006 Dec;44(6):1675-84. doi: 10.1002/hep.21440. Hepatology. 2006. PMID: 17133499 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

623 results

Search Page